Craig B. Granowitz

2022

In 2022, Craig B. Granowitz earned a total compensation of $1.6M as Senior Vice President and Chief Medical Officer at Lexicon Pharmaceuticals, a 66% increase compared to previous year.

Compensation breakdown

Bonus$189,520
Option Awards$631,881
Salary$467,459
Stock Awards$268,000
Other$14,162
Total$1,571,022

Granowitz received $631.9K in option awards, accounting for 40% of the total pay in 2022.

Granowitz also received $189.5K in bonus, $467.5K in salary, $268K in stock awards and $14.2K in other compensation.

Rankings

In 2022, Craig B. Granowitz's compensation ranked 2,148th out of 5,760 executives tracked by ExecPay. In other words, Granowitz earned more than 62.7% of executives.

ClassificationRankingPercentile
All
2,148
out of 5,760
63rd
Division
Manufacturing
1,154
out of 3,136
63rd
Major group
Chemicals And Allied Products
498
out of 1,422
65th
Industry group
Drugs
458
out of 1,323
65th
Industry
Pharmaceutical Preparations
332
out of 969
66th
Source: SEC filing on March 26, 2024.

Granowitz's colleagues

We found four more compensation records of executives who worked with Craig B. Granowitz at Lexicon Pharmaceuticals in 2022.

2022

Lonnel Coats

Lexicon Pharmaceuticals

Chief Executive Officer

2022

Jeffrey Wade

Lexicon Pharmaceuticals

Chief Financial Officer

2022

Brian Crum

Lexicon Pharmaceuticals

General Counsel

2022

Alan Main

Lexicon Pharmaceuticals

Executive Vice President, Innovation and Chemical Sciences

News

You may also like